MANCUSO, GAIA
 Distribuzione geografica
Continente #
AS - Asia 210
NA - Nord America 146
EU - Europa 118
SA - Sud America 28
AF - Africa 2
Totale 504
Nazione #
US - Stati Uniti d'America 131
SG - Singapore 95
CN - Cina 70
SE - Svezia 28
IT - Italia 24
BR - Brasile 20
DE - Germania 20
HK - Hong Kong 18
GB - Regno Unito 13
RU - Federazione Russa 11
VN - Vietnam 11
CA - Canada 8
MX - Messico 6
PL - Polonia 6
AR - Argentina 5
UA - Ucraina 5
IN - India 4
JP - Giappone 3
AT - Austria 2
BD - Bangladesh 2
EC - Ecuador 2
ES - Italia 2
IR - Iran 2
LT - Lituania 2
NL - Olanda 2
TR - Turchia 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
FI - Finlandia 1
FR - Francia 1
GT - Guatemala 1
IQ - Iraq 1
KZ - Kazakistan 1
PY - Paraguay 1
Totale 504
Città #
Singapore 59
Shanghai 20
Hong Kong 18
Beijing 15
Ashburn 14
Munich 14
Dallas 13
New York 13
Los Angeles 12
Hefei 9
Milan 8
Vaprio d'Adda 8
Boardman 6
Warsaw 6
Poplar 5
Bergamo 4
Brooklyn 4
Denver 4
Kyiv 4
Lawrence 4
Montreal 4
Nuremberg 4
Princeton 4
São Paulo 4
Boston 3
Ho Chi Minh City 3
Moscow 3
Pune 3
Querétaro 3
Tokyo 3
Amsterdam 2
Ankara 2
Annapolis 2
City of London 2
Council Bluffs 2
Haiphong 2
Hanoi 2
Ljungby 2
Mexico City 2
Orem 2
Stockholm 2
Tampa 2
Toronto 2
Almaty 1
Anápolis 1
Aracaju 1
Atlanta 1
Augusta 1
Belo Horizonte 1
Bexley 1
Boydton 1
Bragança Paulista 1
Campos dos Goytacazes 1
Cape Town 1
Caxias do Sul 1
Changsha 1
Charleston 1
Charlotte 1
Chatham 1
Chengdu 1
Chennai 1
Chesapeake 1
Chicago 1
Ciudad del Este 1
Clarksburg 1
Contagem 1
Erbil 1
Falkenstein 1
Florianópolis 1
Fortaleza 1
Guatemala City 1
Hacienda Ibarra 1
Helsinki 1
Honolulu 1
Indianapolis 1
Itajaí 1
Jiaxing 1
Johannesburg 1
Kansas City 1
London 1
Lviv 1
Ma'anshan 1
Magé 1
Mar de Ajó 1
Monte Grande 1
Omsk 1
Perm 1
Porto Alegre 1
Providence 1
Qingdao 1
Quito 1
Raleigh 1
Recife 1
Remanso 1
San Andrés de Giles 1
San Juan del Río 1
Santa Clara 1
Santo André 1
Sastre 1
St Petersburg 1
Totale 357
Nome #
Efficacy and safety of rituximab biosimilar (CT-P10) in IgG4-related disease: an observational prospective open-label cohort study 66
Clinical phenotypes of IgG4-related disease reflect different prognostic outcomes 60
Urgent manifestations of immunoglobulin G4-related disease 58
Igg4-related disease of the oral cavity. Case series from a large single-center cohort of italian patients 55
Catastrophic antiphospholipid syndrome presenting with aortic barrage: case report and review of the literature 55
Clinical features and outcomes of COVID-19 in patients with IgG4-related disease: A European multi-centre study 50
Persistence of circulating T-follicular helper cells after rituximab is associated with relapse of IgG4-related disease 46
Utility of the “2019 ACR/EULAR classification criteria” for the management of patients with IgG4-related disease 44
JN.1 variants circulating in Italy from October 2023 to April 2024: genetic diversity and immune recognition 42
Colchicine as a new therapeutic option for antithyroid arthritis syndrome 39
Totale 515
Categoria #
all - tutte 3.443
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.443


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 0 0 1 1 0 0 0 0 0
2021/20224 0 0 0 1 0 0 0 0 1 2 0 0
2022/202355 9 8 4 0 0 4 22 7 0 0 1 0
2023/202453 0 6 0 7 3 11 1 11 0 1 5 8
2024/2025136 10 5 7 3 6 12 19 17 20 3 6 28
2025/2026264 54 35 13 82 75 5 0 0 0 0 0 0
Totale 515